Marksans Pharma informs about press release

07 Aug 2023 Evaluate
Marksans Pharma has informed that it enclosed press release titled ‘Marksaris announces completion of US FDA Post-marketing Adverse Drug Experience (PADE) inspection’.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

163.10 -6.85 (-4.03%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×